Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Bioactive Lipids in Lipid Disorders: a Pilot Study of 2-HOBA Supplementation in Individuals With Elevated Lipoprotein(a)

NCT07198009 is registered in ClinicalTrials.gov with The Miriam Hospital as lead sponsor.

NCT NCT07198009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07198009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Bioactive Lipids in Lipid Disorders: a Pilot Study of 2-HOBA Supplementation in Individuals With Elevated Lipoprotein(a)
Lead sponsor
The Miriam Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
November 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated lp(a), hyperlipidemia